The MiningNewsWire Podcast

Exorbitant costs underscored by byzantine processes plague today’s healthcare systems, creating an $8.45 trillion global healthcare market in 2018, which represents about 10% of GDP in developed countries. Safe to say, the industry is looking for solutions, particularly more efficient ones that improve health outcomes and lower direct and indirect costs. The answer is found in technology, with healthtech (healthcare technology) and medtech (medical technology) buzzwords speaking to leveraging next-generation innovation in a bid to flatten the healthcare spending curve. New applications are being launched daily, and uptake is accelerating, fanned by the COVID-19 pandemic that bolstered adoption of self-diagnostic and remote solutions that have been embraced by health insurers and individuals alike. Some companies, such as Nemaura Medical Inc. (NASDAQ: NMRD) (Profile), are specializing in certain areas of unmet medical need, such as diabetes and obesity for NMRD. Others, including some of the most recognized names in the world such as Tesla Inc. (NASDAQ: TSLA), Apple Inc. (NASDAQ: AAPL), Garmin Ltd. (NASDAQ: GRMN) and Amazon.com Inc. (NASDAQ: AMZN), demonstrate the tremendous opportunity at hand for investments in new technologies and healthtech.

Exorbitant costs underscored by byzantine processes plague today’s healthcare systems, creating an $8.45 trillion global healthcare market in 2018, which represents about 10% of GDP in developed countries. Safe to say, the industry is looking for solutions, particularly more efficient ones that improve health outcomes and lower direct and indirect costs. The answer is found in technology, with healthtech (healthcare technology) and medtech (medical technology) buzzwords speaking to leveraging next-generation innovation in a bid to flatten the healthcare spending curve. New applications are being launched daily, and uptake is accelerating, fanned by the COVID-19 pandemic that bolstered adoption of self-diagnostic and remote solutions that have been embraced by health insurers and individuals alike. Some companies, such as Nemaura Medical Inc. (NASDAQ: NMRD) (Profile), are specializing in certain areas of unmet medical need, such as diabetes and obesity for NMRD. Others, including some of the most recognized names in the world such as Tesla Inc. (NASDAQ: TSLA), Apple Inc. (NASDAQ: AAPL), Garmin Ltd. (NASDAQ: GRMN) and Amazon.com Inc. (NASDAQ: AMZN), demonstrate the tremendous opportunity at hand for investments in new technologies and healthtech.

Look a little closer, and it’s clear that the world has entered a major global inflection point in the modern history of digital media. This new era of digital media is set to reshape the future of social fabric and revolutionize how brands connect with their consumers. The increasing innovation and intelligence in digital media tactics and strategies is making consumer messaging amazingly native and relevant. This personable approach  to online consumer targeting is providing ways to better serve brands by connecting to current and potential target consumers while cutting through the noise. As recently as 2019, mobile surpassed television on total time spent, and digital media has since rocketed past traditional media and advertising tactics. In fact many of the more established digital market tactics have become antiquated. Email marketing is dead, and traditional web banner ads are on life support. Brands understand that it takes more than a flash ad or a quick plug to inspire consumers. Enter the AI-driven martech and digital media software solutions market where innovative content, measurement and distribution solutions reside in all-encompassing marketing strategies engaging and communicating with target audiences through next-generation technology like that of DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) (Profile) to win and keep consumers’ interest and loyalty. The rapid evolution of the marketplace often benefits smaller companies such as DGTL, IZEA Worldwide Inc. (NASDAQ: IZEA), The Trade Desk (NASDAQ: TTD), Acuity Ads Holdings Inc. (TSX: AT) and EQ Inc. (TSX.V: EQ), as they can be more nimble and generally innovative compared to international CRM juggernauts in helping brands reach their objectives.

Look a little closer, and it’s clear that the world has entered a major global inflection point in the modern history of digital media. This new era of digital media is set to reshape the future of social fabric and revolutionize how brands connect with their consumers. The increasing innovation and intelligence in digital media tactics and strategies is making consumer messaging amazingly native and relevant. This personable approach  to online consumer targeting is providing ways to better serve brands by connecting to current and potential target consumers while cutting through the noise. As recently as 2019, mobile surpassed television on total time spent, and digital media has since rocketed past traditional media and advertising tactics. In fact many of the more established digital market tactics have become antiquated. Email marketing is dead, and traditional web banner ads are on life support. Brands understand that it takes more than a flash ad or a quick plug to inspire consumers. Enter the AI-driven martech and digital media software solutions market where innovative content, measurement and distribution solutions reside in all-encompassing marketing strategies engaging and communicating with target audiences through next-generation technology like that of DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) (Profile) to win and keep consumers’ interest and loyalty. The rapid evolution of the marketplace often benefits smaller companies such as DGTL, IZEA Worldwide Inc. (NASDAQ: IZEA), The Trade Desk (NASDAQ: TTD), Acuity Ads Holdings Inc. (TSX: AT) and EQ Inc. (TSX.V: EQ), as they can be more nimble and generally innovative compared to international CRM juggernauts in helping brands reach their objectives.

Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in the United States, or 108 million people, have hypertension, yet only about one out of every four have their condition under control. That’s a big problem considering hypertension increases risks for heart disease and stroke, which are, respectively, the no. 1 and no. 5 leading causes of death in the nation each year. To that point, the CDC names hypertension as a primary or contributing cause in nearly half a million deaths annually in the U.S. Hypertension treatment options vary tremendously from meditation to conventional drugs, with what looks to be a promising new innovation on the horizon from Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile). Lexaria is proving that its proprietary DehydraTECH(TM) technology repeatedly delivers strong therapeutic responses, without the side effects of today’s drugs. Lexaria is looking to throw its hat into the ring with majors in the market today that are making billions of dollars by treating high blood pressure and other leading causes of death, including Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Moderna Inc. (NASDAQ: MRNA).

Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in the United States, or 108 million people, have hypertension, yet only about one out of every four have their condition under control. That’s a big problem considering hypertension increases risks for heart disease and stroke, which are, respectively, the no. 1 and no. 5 leading causes of death in the nation each year. To that point, the CDC names hypertension as a primary or contributing cause in nearly half a million deaths annually in the U.S. Hypertension treatment options vary tremendously from meditation to conventional drugs, with what looks to be a promising new innovation on the horizon from Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile). Lexaria is proving that its proprietary DehydraTECH(TM) technology repeatedly delivers strong therapeutic responses, without the side effects of today’s drugs. Lexaria is looking to throw its hat into the ring with majors in the market today that are making billions of dollars by treating high blood pressure and other leading causes of death, including Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Moderna Inc. (NASDAQ: MRNA).

FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”) has hired engineer Dr. Ghassan Chehade, one of the co-inventors named on the provisional patent of the Company’s technology that will produce carbon-free ammonia (“NH3”). Dr. Chehade worked with Dr. Ibrahim Dincer on the original development of the Company’s core NH3 technology. He has joined the Company as Lead Project Engineer.

To view the full press release, visit https://nnw.fm/PSd7q

FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”) has hired engineer Dr. Ghassan Chehade, one of the co-inventors named on the provisional patent of the Company’s technology that will produce carbon-free ammonia (“NH3”). Dr. Chehade worked with Dr. Ibrahim Dincer on the original development of the Company’s core NH3 technology. He has joined the Company as Lead Project Engineer.

To view the full press release, visit https://nnw.fm/PSd7q

Canada produces sufficient green electricity in off-peak demand hours to produce enough carbon-free ammonia (“NH3”) to replace the use of fossil fuels for 100% of the passenger and freight aviation and rail, passenger bus, freight trucking, freight rail and freight marine shipping in the country, according to a study commissioned by FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”). If all carbon-free ammonia were used, the result would be a 15.3% reduction in Canada’s total greenhouse gas emissions. [Link to study summary: https://ml.globenewswire.com/Resource/Download/5ee10c6a-ba72-409f-bc0c-be756681fae9]

To view the full press release, visit https://nnw.fm/Yvz2e

Canada produces sufficient green electricity in off-peak demand hours to produce enough carbon-free ammonia (“NH3”) to replace the use of fossil fuels for 100% of the passenger and freight aviation and rail, passenger bus, freight trucking, freight rail and freight marine shipping in the country, according to a study commissioned by FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”). If all carbon-free ammonia were used, the result would be a 15.3% reduction in Canada’s total greenhouse gas emissions. [Link to study summary: https://ml.globenewswire.com/Resource/Download/5ee10c6a-ba72-409f-bc0c-be756681fae9]

To view the full press release, visit https://nnw.fm/Yvz2e